BioLargo Balance Sheet Health
Financial Health criteria checks 6/6
BioLargo has a total shareholder equity of $6.0M and total debt of $380.0K, which brings its debt-to-equity ratio to 6.4%. Its total assets and total liabilities are $10.3M and $4.3M respectively.
Key information
6.4%
Debt to equity ratio
US$380.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.88m |
| Equity | US$5.98m |
| Total liabilities | US$4.32m |
| Total assets | US$10.31m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BLGO's short term assets ($7.4M) exceed its short term liabilities ($3.2M).
Long Term Liabilities: BLGO's short term assets ($7.4M) exceed its long term liabilities ($1.1M).
Debt to Equity History and Analysis
Debt Level: BLGO has more cash than its total debt.
Reducing Debt: BLGO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BLGO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BLGO has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 8.7% each year.